Mechanisms of chondrocyte survival and matrix synthesis during hypoxia

Current Rheumatology Reviews

Volumn 3, Issue 1, 2007, Pages 3-9

  Pfander, David ^a,b   Grimmer, Claudia ^a   Müller, Lutz ^a   Aigner, Thomas ^c   Cramer, Thorsten ^d  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^b Department of Orthopedic Rehabilitation ^*  (Germany)

^c UNIVERSITY OF LEIPZIG   (Germany)

^d CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Cartilage; HIF 1; Hypoxia; OA

Indexed keywords

ADENOSINE TRIPHOSPHATE; COLLAGEN TYPE 2; HYPOXIA INDUCIBLE FACTOR 1ALPHA; PROTEOGLYCAN;

ADAPTATION; ANAEROBIC METABOLISM; ARTERY; ARTICULAR CARTILAGE; BIOSYNTHESIS; CARTILAGE CELL; CELL DEATH; CELL FUNCTION; CELL SURVIVAL; ENERGY YIELD; EXTRACELLULAR MATRIX; GROWTH PLATE; HYPOXIA; MICROENVIRONMENT; NONHUMAN; NUTRIENT; OSTEOARTHRITIS; OXYGEN DIFFUSION; OXYGEN TENSION; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN INDUCTION; PROTEIN SYNTHESIS; PUBLISHING; REVIEW; RODENT;

EID: 34247169420     PISSN: 15733971     EISSN: None     Source Type: Journal    
DOI: 10.2174/157339707779815759     Document Type: Review

References (63)

1. Semenza G. Regulation of mammalian O2 homeostasis by hypoxia-inducible factor 1. Annu Rev Cell Dev Biol 1999; 15: 551-78
2. Lee RB, Urban JP: Evidence for a negative Pasteur effect in articular cartilage. Biochem J 1997; 321: 95-102.
3. Silver IA. Measurement of pH and ionic composition of pericellular sites. Philos Trans R Soc Lond B Biol Sci 1975; 271: 261-72.
4. Brighton CT, Heppenstall RB. Oxygen tensions in zones of the epipyseal plate, the mataphysis and diaphysis. An in vitro and in vivo study in rats and rabbits. J Bone Joint Surg (Am) 1971; 53: 719-28.
5. Rajpurohit R, Koch CJ, Tao Z, Teixeira CM, Shapiro IM. Adaptation of chondrocytes to low oxygen tension: relationship between hypoxia and cellular metabolism. J Cell Physiol 1996; 168: 424-32.
6. Hanahan D, Weinberg RA. The hallmarks of cancer. Cell 2000; 100: 57-70.
7. Semenza G, Roth P, Fang H, Wang G. Transcriptional regulation of genes encoding glycolytic enzymes by hypoxia-inducible factor 1. J Biol Chem 1994; 269: 23757-63.
8. Wang GL, Semenza GL. Characterization of hypoxia-inducible factor 1 and regulation of DNA binding activity by hypoxia. J Biol Chem 1993; 268: 21513-8.
9. Wang GL, Semenza GL. Purification and chartecterization of hypoxia-inducible factor 1. J Biol Chem 1995; 270: 1230-7.
10. Distler JHW, Wenger RH, Gassmann M, et al. Physiological responses to hypoxia and implications for hypoxia-inducible factors in the pathogenesis of rheumatoid arthritis. Arthritis Rheum 2004; 50: 10-23.
11. Ivan M, Kondo K, Yang H, et al. HIFalpha targeted for VHL-mediated destruction by proline hydroxylation: implications for O2 sensing. Science 2001; 292: 464-8.
12. 2-regulated prolyl hydroxylation. Science 2001; 292: 468-72.
13. Wang V, Davis DA, Haque M, Huang LE, Yarchoan R. Differential gene up-regulation by hypoxia-inducible factor-1a and hypoxia-inducible factor-2a in HEK293T cells. Cancer Res 2005; 65: 3299-306.
14. Semenza GL. Hif-1, O(2), and the 3 phds. how animal cells signal hypoxia to the nucleus. Cell 2001; 107: 1-3.
15. Jung YJ, Isaacs JS, Lee S, Trepel J, Neckers L. EL-1beta-mediated up-regulation of HIF-1alpha via an NFkappaB/COX-2 pathway identifies HIF-1 as a critical link between inflammation and oncogenesis. FASEB J 2003; 32: 2115-7.
16. Chang H, Shyu KG, Wang BW, Kuan P. Regulation of hypoxia-inducible factor-1 alpha by cyclical mechanical stretch in rat vascular smooth muscle cells. Clin Sci (Lond) 2003; 105:447-56.
17. Semenza GL. HIF-1 and human disease: one highly involved factor. Genes Dev 2000; 14: 1983-91.
18. Maxwell PH, Dachs GU, Gleadle JM, et al. Hypoxia-inducible factor-1 modulates gene expression in solid tumors and influences both angiogenesis and tumor growth. Proc Natl Acad Sci USA 1997; 94: 8104-9.
19. Cramer T, Yamanishi Y, Clausen BE, et al. HIF-1alpha Is Essential for Myeloid Cell-Mediated Inflammation. Cell 2003; 112: 645-57.
20. Ryan HE, Lo J, Johnson RS. HIF-1 alpha is required for solid tumor formation and embryonic vascularization. EMBO J 1998; 17: 3005-15.
21. Kotch LE, Iyer NV, Laughner E, Semenza GL. Defective vascularization of HIF-1 alpha null embryos is not associated with VEGF deficiency but with mesenchymal cell death. Dev Biol 1999; 209: 254-67.
22. Kronenberg H. Developmental regulation of the growth plate. Nature 2003; 423: 332-6.
23. Erlebacher A, Filavaroff EH, Gitelman SE, Derynck R. Toward a molecular understanding of skeletal development. Cell 1995; 80: 371-8.
24. Kirsch T, Nah HD, Shapiro IM, Pacifici M. Regulated production of mineralization-competent matrix vesicles in hypertrophic chondrocytes. J Cell Biol 1997; 137: 1149-60.
25. Schipani E, Ryan HE, Didrickson S, Kobayashi T, Knight M, Johnson RS. Hypoxia in cartilage: HIF-1alpha is essential for chondrocyte growth arrest and survival. Genes Dev 2001; 15: 2865-76.
26. Pfander D, Cramer T, Schipani E, Johnson RS. HIF-1alpha controls extracellular matrix synthesis by epiphyseal chondrocytes. J Cell Sci 2003; 116: 1819-26.
27. Gerber HP, Vu TH, Ryan AM, Kowalski J, Werb Z, Ferrara N. VEGF couples hypertrophic cartilage remodeling, ossification and angiogenesis during endochondral bone formation. Nat Med 1999; 5: 623-8.
28. Carlevaro MF, Cermelli S, Cancedda R, Descalzi Cancedda F. Vascular endothelial growth factor (VEGF) in cartilage neovascularization and chondrocyte differentiation: auto-paracrine role during endochondral bone formation. J Cell Sci 2000; 113: 59-69.
29. Cramer T, Schipani E, Johnson RS, Swoboda B, Pfander D. Expression of VEGF isoforms by epiphyseal chondrocytes during low-oxygen tension is HIF-1alpha dependent. Osteoarthritis Cartilage 2004; 12: 433-9.
30. Zelzer E, Mamluk R, Ferrara N, Johnson RS, Schipani E, Olsen BR. VEGFA is necessary for chondrocyte survival during bone development Development 2004; 131: 2161-71.
31. Maes C, Stockmans I, Moermans K, et al. Soluble VEGF isoforms are essential for establishing vascularization and regulating chondrocyte development and survival. J Clin Invest 2004; 113: 188-99.
32. Pfander D, Kobayashi T, Knight MC, et al. Deletion of Vhlh in chondrocytes reduces cell proliferation and increases matrix deposition during growth plate development. Development 2004; 131: 2497-508.
33. Robins JC, Akeno N, Mukherjee A, et al. Hypoxia induces chondrocyte-specific gene expression in mosenchymal cells in association with transcriptional activation of Sox9. Bone 2005; 37: 313-22.
34. Marcus RE. The effect of low oxygen concentration in growth, glycolysis and sulphate incorporation by articular chondrocytes in monolayer culture. Arthritis Rheum 1973; 16: 646-56.
35. Hardingham TE. Proteoglycans - their structure interactions and molecular organization in cartilage. Biochem Soc Trans 1981; 9: 489-97.
36. Heinegard D, Oldberg A. Structure and biology of cartilage and bone matrix noncollagenous macromolecules. FASEB J 1989; 3: 2042-51.
37. Stockwell RA. Cartilage-Structure, Function and Biochemistry, Vol 1. Edited by Hall BK. New York: Academic Press; 1983.
38. Bruckner P, van der Rest M. Structure and function of cartilage collagens. Microsc Res Tech 1994; 28: 378-84.
39. Urban JP. The chondrocyte: A cell under pressure. Br J Rheumatol 1994; 33: 901-8.
40. O'Hara B, Urban JP, Maroudas A. Infuence of cyclic loading on the nutrition of articular cartilage. Ann Rheum Dis 1990; 49: 536-9.
41. Schneider U, Miltner O, Thomsen M, Graf J, Niethard F. Intraartikuläre Sauerstoffpartialdruckmesung unter funtionellen Bedingungen. Z Orthop 1996, 134: 422-5.
42. Schneider U, Miltner O. Graf J, Niethard F. Intraarticular oxygen partial pressure measurements under working conditions. Orthop Trans 1994; 4:58.
43. Lund-Olesen K. Oxygen tension in synovial fluids. Arthritis Rheum 1970; 13: 769-76.
44. Richman AI, Su EY, Ho G. Reciprocal relationship of synovial fluid volume and oxygen tension. Arthritis Rheum 1981; 24: 701-5.
45. Maroudas A, Schneiderman R, Popper O. The role of water, proteoglycan, and collagen in solute transport in cartilage. In Articular cartilage and osteoarthritis. Edited by Kuettner KE: Raven Press Ltd.; 1992: 355-71. vol 1.
46. Ogata K, Whiteside L, Lesker P. Subchondral route for nutrition to articular cartilage in the rabbit. J Bone Joint Surg (Am) 1978; 60: 905-10.
47. Brucker PU, Izzo NJ, Chu CR. Tonic activation of hypoxia-inducible factor 1alpha in avascular cartilage and implication for metabolic homeostasis. Arthritis Rheum 2005; 52: 3181-91.
48. Yudoh K, Nakamura H, Masuko-Hongo K, Kato T, Nishioka K. Catabolic stress induces expression of hypoxia-inducible factor (HIF)-1a in articular chondrocytes: involvement of HIF-1a in the pathogenesis of osteoarthritis. Arthritis Res Ther 2005; 7: 904-14.
49. Aigner T, Zien A, Gehrsitz A, Gebbard PM, McKenna L. Anabolic and catabolic gene expression pattern analysis in normal versus osteoarthritic cartilage using complementary DNA-array technology. Arthritis Rheum 2001; 44: 2777-89.
50. Pfander D, Kortje D, Zimmermann R, et al. Vascular endothelial growth factor in articular cartilage of healthy and osteoarthritic human knee joints. Ann Rheum Dis 2001; 60: 1070-3.
51. Pufe T, Petersen W, Tillmann B, Mentlein R. The splice variants VEGF121 and VEGF189 of the angiogenic peptide vascular endothelial growth factor are expressed in osteoarthritic cartilage. Arthritis Rheum 2001; 44: 1082-8.
52. Pfander D, Cramer T, Swoboda B: Hypoxia, and HIF-1alpha in osteoarthritis. International Orthopaedics 2005, 29:6-9.
53. Coimbra IB, Jimenez SA, Hawkins DF, Piera-Velazquez S, Stokes DG. Hypoxia-inducible factor 1alpha expression in human normal and osteoarthritic chondrocytes. Osteoarthritis Cartilage 2004; 12: 336-45.
54. Hansen U, Schunke M, Domm C, et al. Combination of reduced oxygen tension and intermittent hydrostatic pressure: a useful tool in articular cartilage tissue engineering. J Biomech 2001; 34: 941-9.
55. Aigner T, Zien A, Gehrsitz A, Gebhard PM, McKenna L. Anabolic and catabolic gene expression pattern analysis in normal versus osteoarthritic cartilage using DNA-Array technology. Arthritis Rheumatism 2001; 44: 2777-89.
56. Lippiello L, Hall D, Mankin H. Collagen synthesis in normal and osteoarthritic human cartilage. J Clin Invest 1977; 59: 593-600.
57. Mankin H, Dorfman H, Lippiello L, Zarins A. Biochemical and metabolic abnormalities in articular cartilage from osteoarthritic human hips. II. Correlation of morphology with biochemical and metabolic data. J Bone Joint Surg (Am) 1971; 53: 523-37.
58. Swoboda, B, Pullig O. Kirsch T, Kladny B, Steinhäuser B, Weseloh G. Increased content of type VI collagen epitopes in human osteoarthritic cartilage. Quantitation by inhibition-ELISA. J Orthop Res 1998; 16:96-9.
59. Nelson F, Dahlberg L, Laverty S, et al.: Evidence for altered synthesis of type II collagen in patients with osteoarthritis. J Clin Invest 1998; 102:2115-25.
60. Anmunen P, Autio-Harmainen H, Kivirikko KI. The novel type II prolyl 4-hydroxylase is the main enzyme from in chondrocytes and capillary endothelial cells, whereas the type I enzyme predominates in most cells. J Biol Chem 1998; 273: 5989-92.
61. Annunen P, Helaakoski T, Myllyharju J, Veijola J, Pihlajaniemi T, Kivirikko KI. Cloning of the human prolyl 4-hydroxylase alpha subunit isoform alpha(II) and characterization of the type II enzyme tetramer The alpha(I) and alpha(II) subunits do not from a mixed alpha(I)alpha(II)beta2 tetramer. J Biol Chem 1997; 272: 17342-8.
62. Kukkola L, Hieta R, Kivirikko KI, Myllyharuju J. Identification and characterization of a third human, rat, and mouse collagen prolyl 4-hydroxylase isoenzyme. J Biol Chem 2003; 278: 47685-93.
63. Grimmer C, Balbus N, Lang U, et al. Regulation of type II collagen synthesis during osteoarthritis by prolyl-4-hydroxylases. Possible influence of low oxygen levels. Am J Pathol 2006; 169: 491-502.